Simple HealthKit is a technology company.
Simple HealthKit has raised $8.0M across 1 funding round.
Simple HealthKit has raised $8.0M in total across 1 funding round.
Simple HealthKit is a healthcare technology company founded in 2017 that provides an end-to-end, human-centric platform for diagnostics, treatment, and follow-up care, primarily through at-home and in-clinic solutions.[1][2] It serves large organizations such as retailers (e.g., Walmart), pharmacies, employers, educational institutions, and public health entities, reaching over 1.5 million people, with a focus on underserved populations facing barriers like siloed healthcare services.[1][2] The platform addresses gaps in accessible testing for respiratory health, chronic conditions, and more by integrating diagnostics via its CLIA-certified lab, telehealth, and prescriptions, boasting strong traction including 99.86% of lab samples processed within 24 hours, near-100% registration completion rates, 100% follow-up on abnormal results, and 46% testing volume growth from 2021 to 2022.[1][2]
Simple HealthKit was founded in 2017 (with some sources noting 2018 as the operational start) in Fremont, California, by Sheena Menezes (Co-Founder & CEO, PhD in biochemistry and bioengineering, former Senior Principal Scientist at Scanadu), Linus Aranha (Co-Founder & CTO, former Co-Founder & Chief Architect at Prosimo.io), and early team members including Jerzy Majka and Lisa Le.[1][2] Menezes and her team launched the company to tackle healthcare inequities, driven by frustrations with fragmented systems where patients are often "dropped" during testing, labs, telehealth, or prescriptions—especially in underserved markets.[2] Early traction came from building diagnostics for respiratory and chronic conditions, establishing a CLIA-certified lab, and securing partnerships; a pivotal moment was the 2023 deal with Walmart to expand at-home testing access, alongside $12 million in funding from investors like Initialized Capital, Kapor Capital, Quest Venture Partners, and Kleiner Perkins.[1][2]
Simple HealthKit rides the wave of digital health and at-home diagnostics, accelerated by post-pandemic demand for convenient, equitable care amid rising chronic disease prevalence and healthcare silos.[2] Timing is ideal as market forces like health equity initiatives, retailer telehealth expansions (e.g., Walmart deal), and regulatory support for CLIA labs favor scalable platforms over fragmented services.[1][2] It influences the ecosystem by enabling organizations to offer "diagnostics-as-a-service," reducing drop-offs in underserved communities and setting a model for integrated care that could pressure incumbents to prioritize follow-up and accessibility.[2]
Simple HealthKit is poised for accelerated growth through deeper retailer integrations and product expansions into physician-ordered tests, potentially hitting $107M ARR amid diagnostics market tailwinds.[2] Trends like AI-enhanced labs, value-based care, and health equity mandates will shape its path, evolving its influence from niche partner to broader ecosystem leader in human-centric health tech—reinforcing its founding promise of care "for all" in an increasingly accessible landscape.[1][2]
Simple HealthKit has raised $8.0M in total across 1 funding round.
Simple HealthKit's investors include Abstract Ventures, Alumni Ventures, Amino Capital, Bling Capital, C2 Investment, Kevin Ding, Founders Fund, Greenoaks Capital, Helium-3 Ventures, Jigsaw VC, Kleiner Perkins, Primitive Ventures.
Simple HealthKit has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Series A in February 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2023 | $8.0M Series A | Abstract Ventures, Alumni Ventures, Amino Capital, Bling Capital, C2 Investment, Kevin Ding, Founders Fund, Greenoaks Capital, Helium-3 Ventures, Jigsaw VC, Kleiner Perkins, Primitive Ventures, Quiet Capital, Saga, Tribe Capital, UpHonest Capital, Y Combinator, Elad Gil, Matt Bellamy, Mike Vernal, Samvit Ramadurgam, Sohail Prasad, Sue Xu |